1. Home
  2. FET vs DRUG Comparison

FET vs DRUG Comparison

Compare FET & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

HOLD

Current Price

$53.64

Market Cap

645.5M

Sector

Industrials

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$74.50

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FET
DRUG
Founded
2005
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
645.5M
707.1M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
FET
DRUG
Price
$53.64
$74.50
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$129.25
AVG Volume (30 Days)
124.3K
255.8K
Earning Date
04-30-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
92.64
N/A
EPS
0.39
N/A
Revenue
$791,474,000.00
N/A
Revenue This Year
$7.35
N/A
Revenue Next Year
$6.95
N/A
P/E Ratio
$133.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.93
$23.18
52 Week High
$65.43
$123.75

Technical Indicators

Market Signals
Indicator
FET
DRUG
Relative Strength Index (RSI) 44.20 37.08
Support Level $48.86 $70.35
Resistance Level $63.59 $77.01
Average True Range (ATR) 2.65 5.15
MACD -0.28 -1.01
Stochastic Oscillator 45.66 8.31

Price Performance

Historical Comparison
FET
DRUG

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a manufacturing company serving the oil, natural gas, industrial, and renewable energy industries. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. The company operates in two reportable segments: Drilling and Completions, and Artificial Lift and Downhole. Maximum revenue is generated from the Drilling and Completions segment, which offers products used in the drilling process, and other products like hydraulic fracturing pumps, ROVs and trenchers, submarine rescue vehicles, etc. Geographically, the firm generates maximum revenue from the U.S., followed by Canada, Middle East, Europe and Africa, Asia-Pacific, and Latin America.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: